Open Access

Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux

  • Authors:
    • Uddin Md Nazim
    • Honghua Yin
    • Sang‑Youel Park
  • View Affiliations

  • Published online on: April 6, 2020     https://doi.org/10.3892/ijmm.2020.4566
  • Pages: 280-288
  • Copyright: © Nazim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tumor necrosis factor (TNF)‑related apoptosis‑inducing ligand (TRAIL), a type II transmembrane protein, is a part of the TNF superfamily of cytokines. Cantharidin, a type of terpenoid, is extracted from the blister beetles (Mylabris genus) used in Traditional Chinese Medicine. Cantharidin elicits antibiotic, antiviral and antitumor effects, and can affect the immune response. The present study demonstrated that a cantharidin and TRAIL combination treatment regimen elicited a synergistic outcome in TRAIL‑resistant DU145 cells. Notably, it was also identified that cantharidin treatment initiated the downregulation of cellular FLICE‑like inhibitory protein (c‑FLIP) and upregulation of death receptor 5 (DR‑5), and sensitized cells to TRAIL‑mediated apoptosis by initiating autophagy flux. In addition, cantharidin treatment increased lipid‑modified microtubule‑associated proteins 1A/1B light chain 3B expression and significantly attenuated sequestosome 1 expression. Attenuation of autophagy flux by a specific inhibitor such as chloroquine and genetic modification using ATG5 small interfering RNA abrogated the cantharidin‑mediated TRAIL‑induced apoptosis. Overall, the results of the present study revealed that cantharidin effectively sensitized cells to TRAIL‑mediated apoptosis and its effects are likely to be mediated by autophagy, the downregulation of c‑FLIP and the upregulation of DR‑5. They also suggested that the combination of cantharidin and TRAIL may be a successful therapeutic strategy for TRAIL‑resistant prostate cancer.
View Figures
View References

Related Articles

Journal Cover

July 2020
Volume 46 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Nazim, U.M., Yin, H., & Park, S. (2020). Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux. International Journal of Molecular Medicine, 46, 280-288. https://doi.org/10.3892/ijmm.2020.4566
MLA
Nazim, U. M., Yin, H., Park, S."Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux". International Journal of Molecular Medicine 46.1 (2020): 280-288.
Chicago
Nazim, U. M., Yin, H., Park, S."Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux". International Journal of Molecular Medicine 46, no. 1 (2020): 280-288. https://doi.org/10.3892/ijmm.2020.4566